Heat Hyperalgesia Induced by Endoneurial Nerve Growth Factor and the Expression of Substance P in Primary Sensory Neurons

REFERENCES

• Baranowski A. P., Priestley J. V., McMahon S. B. Substance P in cutaneous primary sensory neurons—a comparison of models of nerve injury that allow varying degrees of regeneration. Neuroscience 1993; 55: 1025–1036
   PubMed Web of Science ®Google Scholar
• Boucher T. J., Kerr B., Ramer M., Thompson S., McMahon S. B. Neurotrophic factor effects on pain-signaling systems. Proceedings of the 9th World Congress on pain, M. Devor, M. Rowbotham, Z. Wiesenfeld-Hallin. IASP Press, Seattle, WA 2000; 175–189
   Google Scholar
• Bowles W. R., Sabino M., Harding-Rose C., Hargreaves K. M. Nerve growth factor treatment enhances release of immunoreactive calcitonin gene-related peptide but not substance P from spinal dorsal horn slices in rats. Neuroscience Letters 2004; 363: 239–242
   PubMedGoogle Scholar
• Cahill C. M., Coderre T. J. Attenuation of hyperalgesia in a rat model of neuropathic pain after inthratecal pre- or post-treatment with a neurokinin-1 antagonist. Pain 2002; 95: 277–285
   PubMed Web of Science ®Google Scholar
• Calcutt N. A., Stiller C., Gustaffson H., Malmberg A. B. Elevated substance P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats. Brain Research 2000; 856: 20–27
   PubMedGoogle Scholar
• Cameron A. A., Cliffer K. D., Dougherty P. M., Garrison C. J., Willis W. D., Carlton S. M. Time course of degenerative and regenerative changes in the dorsal horn in a rat model of peripheral neuropathy. The Journal of Comparative Neurology 1997; 379: 428–442
   PubMedGoogle Scholar
• Campbell E. A., Gentry C. T., Patel S., Panesar M. S., Walpole C. S. J., Urban L. Selective neurokinin-1 receptor antagonist are anti-hyperalgesic in a model of neuropathic pain in the guinea-pig. Neuroscience 1998; 87: 527–532
   PubMed Web of Science ®Google Scholar
• Donnerer J., Schuligoi R., Stein C., Amann R. Upregulation, release and axonal transport of substance P and calcitonin gene-related peptide in adjuvant inflammation and regulatory function of nerve growth factor. Regulatory Peptides 1993; 46: 150–154
   PubMedGoogle Scholar
• Dubuisson D., Dennis S. G. The formalin test: A quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4: 161–164
   PubMed Web of Science ®Google Scholar
• Duggan A. W., Morton C. R., Zhao Z. Q., Hendry I. A. Noxious heating of the skin releases immunoreactive substance P in the substantia gelatinosa of the cat: A study with antibody microprobes. Brain Research 1987; 403: 345–349
   PubMedGoogle Scholar
• Fitzgerald M., Wall P. D., Goedert M., Emson P. C. Nerve growth factor counteracts the neurophysiological and neurochemical effects of chronic sciatic nerve sections. Brain Research 1985; 332: 131–141
   PubMedGoogle Scholar
• Gaddum J. H., Schild H. Depressor substances in extracts of intestine. The Journal of Physiology (London) 1935; 83: 1–14
   Google Scholar
• Go V. L., Yaksh T. L. Release of substance P from the cat spinal cord. The Journal of Physiology (London) 1987; 391: 141–167
   PubMed Web of Science ®Google Scholar
• Gonzalez M. I., Field M. J., Hughes J., Singh L. Evaluation of selective NK1 receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain. The Journal of Pharmacology and Experimental Therapeuticals 2000; 294: 444–450
   PubMed Web of Science ®Google Scholar
• Hall A. K., Ai X., Hickman G. E., MacPhedran S. E., Nduaguba C. O., Robertson C. P. The generation of neuronal heterogeneity in a rat sensory ganglion. The Journal of Neuroscience 1997; 17: 2775–2784
   PubMed Web of Science ®Google Scholar
• Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988; 32: 77–88
   PubMed Web of Science ®Google Scholar
• Henry J. L., Yashpal K., Pitcher G. M., Chabot J. G., Coderre T. J. Evidence for tonic activation of NK-1 receptors during the second phase of the formalin test in the rat. The Journal of Neuroscience 1999; 19: 6588–6598
   PubMedGoogle Scholar
• Herzberg U., Eliav E., Dorsey J. M., Gracely R. H., Kopin I. J. NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve. Neuroreport 1997; 8: 1613–1618
   PubMedGoogle Scholar
• Hill R. NK1 (substance P) antagonists-why are they not analgesic in humans?. Trends in Pharmacological Sciences 2000; 21: 244–246
   PubMed Web of Science ®Google Scholar
• Honoré P., Menning P. M., Rogers S. D., Nichols M. L., Basbaum A. I., Besson J. M., Mantyh P. W. Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states. The Journal of Neuroscience 1999; 19: 7670–7678
   PubMed Web of Science ®Google Scholar
• Hökfelt T., Kellerth J. O., Nilsson G., Pernow B. Substance P: Localization in the central nervous system and in some primary sensory neurons. Science 1975; 190: 889–890
   PubMed Web of Science ®Google Scholar
• Inaishi Y., Kashihara Y., Sakaguchi M., Nawa H., Kuno M. Cooperative regulation of calcitonin gene-related peptide levels in rat sensory neurons via their central and peripheral processes. The Journal of Neuroscience 1992; 12: 518–524
   PubMedGoogle Scholar
• Jang J. H., Nam T. S., Paik K. S., Leem J. W. Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat. Neurosci Letters 2004; 360: 129–132
   PubMedGoogle Scholar
• Kajander K. C., Pollock C. H., Berg H. Evaluation of hindpaw position in rats during chronic constriction injury (CCI) produced with different suture materials. Experimental Brain Research 1992; 91: 73–78
   PubMedGoogle Scholar
• Kanai Y., Nakazato E., Fujiuchi A., Hara T., Imai A. Involvement of an increased spinal TRPV1 sensitization through its up-regulation in mechanical allodynia of CCI rats. Neurophamacology 2005; 49: 977–984
   PubMed Web of Science ®Google Scholar
• Kawasaki Y., Kohno T., Zhuang Z.-Y., Brenner G. J., Wang H., Van Der Meer C., Befort K., Woolf C. J., Ji R.-R. Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. The Journal of Neuroscience 2004; 24: 8310–8321
   PubMed Web of Science ®Google Scholar
• Khasabov S. G., Ghilardi J. R., Mantyh P. W., Simone D. A. Spinal neurons that express NK-1 receptors modulate descending controls that project through the dorsolateral funiculus. Journal of Neurophysiology 2005; 93: 998–1006
   PubMedGoogle Scholar
• Khasabov S. G., Rogers S. D., Ghilardi J. R., Peters C. M., Mantyh P. W., Simone D. A. Spinal neurons that possess the substance P receptor are required for the development of central sensitization. The Journal of Neuroscience 2002; 22: 9086–9098
   PubMed Web of Science ®Google Scholar
• Kingery W. S., Davies M. F., Clark J. D. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain 2003; 104: 75–84
   PubMedGoogle Scholar
• Li L., Xian C. J., Zhong J.-H., Zhou X.-F. Lumbar 5 ventral root transection-induced upregulation of nerve growth factor in sensory neurons and their target tissues: A mechanism in neuropathic pain. Molecular and Cellular Neuroscience 2003; 23: 232–250
   PubMedGoogle Scholar
• Lindsay R. M., Harmar A. J. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989; 337: 362–364
   PubMed Web of Science ®Google Scholar
• Ma W., Bisby M. A. Increase of preprotachykinin mRNA and substance P immunoreactivity in spared dorsal root ganglion neurons following partial sciatic nerve injury. The European Journal of Neuroscience 1998; 10: 2388–2399
   PubMedGoogle Scholar
• Ma W., Eisenach J. C. Intraplantar injection of a cyclooxygenase inhibitor ketorolac reduces immunoreactivities of substance P, clacitonin gene-related peptide, and dynorphin in the dorsal horn of rats with nerve injury or inflammation. Neuroscience 2003; 121: 681–690
   PubMed Web of Science ®Google Scholar
• Malcangio M., Garrett N. E., Tomlinson D. R. Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord. The European Journal of Neuroscience 1997; 9: 1101–1104
   PubMedGoogle Scholar
• Mansikka H., Sheth R. N., DeVries C., Lee H., Winchurch R., Raja S. N. Nerve injury-induced mechanical but not thermal hyperalgesia is attenuated in neurokinin-1 receptor knockout mice. Experimental Neurology 2000; 162: 343–349
   PubMed Web of Science ®Google Scholar
• Mason L., Moore R. A., Derry S., Edwards J. E., McQuay H. J. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004; 328: 991
   PubMed Web of Science ®Google Scholar
• McCarthy P. W., Lawson S. N. Cell type and conduction velocity of rat primary sensory neurons with substance P-like immunoreactivity. Neuroscience 1989; 28: 745–753
   PubMed Web of Science ®Google Scholar
• Munglani R., Bond A., Smith G. D., Harrison S. M., Elliot P. J., Birch P. J., Hunt S. P. Changes in neuronal markers in a mononeuropathic rat model: Relationship between neuropeptide Y, pre-emptive drug treatment and long-term mechanical hyperalgesia. Pain 1995; 63: 21–31
   PubMedGoogle Scholar
• Neumann S., Doubell T. P., Leslie T., Woolf C. J. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996; 384: 360–364
   PubMed Web of Science ®Google Scholar
• Nichols M. L., Allen B. J., Rogers S. D., Ghilardi J., Honoré P., Luger N. M., Finke M. P., Li J., Lappi D. A., Simone D. A., Mantyh P. W. Transmission of chronic nociception by spinal neurons expressing the substance P receptor. Science 1999; 286: 1558–1561
   PubMed Web of Science ®Google Scholar
• Noguchi K., Kawai Y., Fukuoka T., Senba E., Miki K. Substance P induced by peripheral nerve injury in primary afferent sensory neurons and its effect on dorsal column nucleus neurons. The Journal of Neuroscience 1995; 15: 7633–7643
   PubMed Web of Science ®Google Scholar
• Nolano M., Simone D. A., Wendelschafer-Crabb G., Johnson T., Hazen E., Kennedy W. R. Topical capsaicin in humans: Parallel loss of epidermal nerve fibers and pain sensation. Pain 1999; 81: 135–145
   PubMed Web of Science ®Google Scholar
• Nothias F., Tessler A., Murray M. Restoration of substance P and calcitonin gene-related peptide in dorsal root ganglia and dorsal horn after neonatal sciatic nerve lesion. The Journal of Comparative Neurology 1993; 334: 370–384
   PubMed Web of Science ®Google Scholar
• Ohkubo T., Shibata M., Takahashi H., Inoki R. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord. The Journal of Pharmacology and Experimental Therapeutics 1990; 252: 1261–1268
   PubMedGoogle Scholar
• Pezet S., Malcangio M., McMahon S. B. BDNF: A neuromodulator in nociceptive pathways?. Brain Research 2002; 40: 240–249
   Google Scholar
• Onténiente Pezet S.B., Jullien J., Junier M. P., Grannec G., Rudkin B. B., Calvino B. Differential regulation of NGF receptors in primary sensory neurons by adjuvant-induced arthritis in the rat. Pain 2001; 90: 113–125
   PubMedGoogle Scholar
• Pitcher G. M., Henry J. L. Second phase of formalin-induced excitation of spinal dorsal horn neurons in spinalized rats is reversed by sciatic nerve block. The European Journal of Neuroscience 2002; 15: 1509–1515
   PubMedGoogle Scholar
• Radhakrishnan V., Henry J. L. Novel substance P antagonist, CP-96, 345, blocks responses of cat spinal dorsal horn neurons to noxious cutaneous stimulation and to substance P. Neuroscience Letters 1991; 132: 39–43
   PubMed Web of Science ®Google Scholar
• Ramer M. S., Bisby M. A. Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: Distinct mechanisms revealed by anti-NGF treatment. The European Journal of Neuroscience 1999; 11: 837–846
   PubMedGoogle Scholar
• Richardson P. M., Riopelle R. J. Uptake of nerve growth factor along peripheral and spinal axons of primary sensory neurons. The Journal of Neuroscience 1984; 4: 1683–1689
   PubMed Web of Science ®Google Scholar
• Ruiz G., Baños J.-E. The effect of endoneurial nerve growth factor on calcitonin gene-related peptide expression in primary sensory neurons. Brain Research 2005; 1042: 44–52
   PubMedGoogle Scholar
• Ruiz G., Ceballos D., Baños J.-E. Behavioral and histological effects of endoneurial administration of nerve growth factor: Possible implications in neuropathic pain. Brain Research 2004; 1011: 1–6
   PubMedGoogle Scholar
• Schaible H. G., Jarrott B., Hope P. J., Duggan A. W. Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint in the cat: A study with antibody microprobes. Brain Research 1990; 529: 214–223
   PubMed Web of Science ®Google Scholar
• Stoeckel K., Schwab M. E., Thoenen H. Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: A biochemical and morphological study. Brain Research 1975; 89: 1–14
   PubMed Web of Science ®Google Scholar
• Suzuki R., Morcuende S., Webber M., Hunt S. P., Dickenson A. H. Superficial NK-1-expressing neurons control spinal excitability through activation of descending pathways. Nature Neuroscience 2002; 5: 1319–1326
   PubMed Web of Science ®Google Scholar
• Todd A., Puskár Z., Spike R. C., Hughes C., Watt C., Forrest L. Projection neurons in lamina I of rat spinal cord with the neurokinin 1 receptor are selectively innervated by substance P-containing afferents and respond to noxious stimulation. Journal of Neuroscience 2002; 22: 4103–4113
   PubMedGoogle Scholar
• Traub R. J. The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat. Pain 1996; 67: 151–161
   PubMedGoogle Scholar
• Verge V. M. K., Richardson P. M., Wiesenfeld-Hallin Z., Hökfelt T. Differential influence of nerve growth factor on neuropeptide expression in vivo: A novel role in peptide suppression in adult sensory neurons. Journal of Neuroscience 1995; 15: 2081–2096
   PubMed Web of Science ®Google Scholar
• Von Euler U. S., Gaddum J. H. An unidentified depressor substance in certain tissue extracts. Journal of Physiology 1931; 72: 74–87
   PubMedGoogle Scholar
• Watson G. S., Sufka K. J., Coderre T. J. Optimal scoring strategies and weights for the formalin test in rats. Pain 1997; 70: 53–58
   PubMedGoogle Scholar
• Wiberg M., Ljungberg C., O’Byrne A., Brown R., Whitworth I., Liss A., Terenghi G. Primary sensory neuron survival following targeted administration of nerve growth factor to an injured nerve. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery 1999; 33: 387–392
   PubMedGoogle Scholar
• Yamamoto T., Yaksh T. L. Effects of intrathecal capsaicin and an NK-1 antagonist, CP, 96–345, on the thermal hyperalgesia observed following unilateral constriction of the sciatic nerve in the rat. Pain 1992; 51: 329–334
   PubMed Web of Science ®Google Scholar
• Zimmer A., Zimmer A. M., Baffi J., Usdin T., Reynolds K., König M., Palkovits M., Mezey E. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proceedings of the National Academy of Science 1998; 95: 2630–2635
   PubMed Web of Science ®Google Scholar
• Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109–110
   PubMed Web of Science ®Google Scholar